Results 141 to 150 of about 5,489 (174)

Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations

Allergy and Asthma Proceedings, 2018
Sudeesh K Tantry, Piyush Patel
exaly  

Mometasone/permethrin

Reactions Weekly, 2022
openaire   +1 more source

Adrenal Suppression with Dry Powder Formulations of Fluticasone Propionate and Mometasone Furoate

American Journal of Respiratory and Critical Care Medicine, 2004
Brian Lipworth, Tom C Fardon, Daniel K C Lee   +2 more
exaly  

Mometasone

Reactions Weekly, 2010
openaire   +1 more source

Mometasone Furoate

Drugs, 2012
Susan V Onrust, Harriet M Lamb, S V Onrust   +2 more
exaly  

Divergent effect of mometasone on human eosinophil and neutrophil apoptosis

Life Sciences, 2002
Hannu Kankaanranta, Eeva Moilanen, Ian Adcock   +2 more
exaly  

Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris

Journal of the European Academy of Dermatology and Venereology, 2009
C M Salavastru
exaly  

Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate

Journal of Allergy and Clinical Immunology, 2019
Ioana Agache, Cindy Weinstein, Robert A Nathan   +2 more
exaly  

Mometasone

Reactions Weekly, 2005
openaire   +1 more source

The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma

Journal of Asthma, 2011
Steven S Smugar, Theodore F Reiss
exaly